Previous Article | Next Article 
Journal of Bacteriology, October 2001, p. 5639-5644, Vol. 183, No. 19
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.19.5639-5644.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Novel Macrolide-Specific ABC-Type Efflux Transporter in
Escherichia coli
Nobuyoshi
Kobayashi,1,2
Kunihiko
Nishino,1,2,3 and
Akihito
Yamaguchi1,2,3,*
Faculty of Pharmaceutical Science, Osaka
University, Suita, Osaka 565-0871,2 and
Department of Cell Membrane Biology, Institute of
Scientific and Industrial Research, Osaka University,
Ibaraki,1 and CREST, Japan Science
and Technology Corporation,3 Osaka 567-0047, Japan
Received 12 March 2001/Accepted 10 July 2001
 |
ABSTRACT |
In the Escherichia coli genome, five putative open
reading frame (ORF) clusters, mdlAB,
ybjYZ, yddA, yojHI, and yhiH,
have been assumed to be possible genes for ABC drug efflux transporters (I. T. Paulsen, M. K. Sliwinski, and M. H. Saier, Jr., J. Mol. Biol. 277:573-592, 1998). We cloned all of these
ORFs in multicopy plasmids and investigated the drug
resistance of drug-supersensitive host cells lacking constitutive
multidrug efflux transporter genes acrAB. Among them, only
ybjYZ gave significant erythromycin resistance and
significantly decreased the accumulation of
[14C]erythromycin. Therefore, ybjYZ was
renamed macAB (macrolide-specific ABC-type efflux carrier).
Plasmids carrying both the macA and -B genes
conferred resistance against macrolides composed of 14- and
15-membered lactones but no or weak resistance against 16-membered ones. Neither of the two genes produced resistance alone. The DNA
sequence suggests that MacB is an integral membrane protein with
four transmembrane segments and one nucleotide-binding domain, while
MacA belongs to a membrane fusion protein (MFP) family with a
signal-like sequence at its N terminus. The expression of the histidine-tagged proteins confirmed that MacB is an integral membrane protein and MacA is a peripheral membrane protein. In addition, MacAB
required TolC for its function in a way similar to that of most of the
MFP-dependent transporters in E. coli. MacB is thus a novel
ABC-type macrolide efflux transporter which functions by cooperating
with the MFP MacA and the multifunctional outer membrane channel TolC.
This is the first case of an experimentally identified ABC antibiotic
efflux transporter in gram-negative organisms.
 |
INTRODUCTION |
ATP-binding cassette (ABC)
transporters are the major drug efflux transporters in mammalian cells
that cause multidrug resistance of cancer cells (5). On
the other hand, ABC transporters are involved mainly in the uptake of a
wide range of molecules (13), protein export
(13), and the efflux of toxic metal ions, such as an
arsenite (23), in bacteria. LmrA in a gram-positive
bacterium, Lactococcus lactis (30), has been
the only example of an experimentally identified bacterial ABC
multidrug exporter. A small number of ABC single-drug exporters for
macrolides (22) and daunomycin (21) are also
known in gram-positive bacteria, whereas no functional ABC drug
exporter has been definitely established to exist in gram-negative
bacteria yet (32). The efflux-based multidrug resistance
of gram-negative bacteria is most often conferred by RND
(resistance-nodulation-cell division) family transporters (9,
15), in addition to some SMR (small multidrug resistance) transporters (18). Efflux-based single-drug resistance of
gram-negative bacteria is usually due to plasmid-encoded
MFS (major facilitator superfamily) transporters such as
tetracycline-H+ antiporters (11, 31).
Complete genomic DNA sequences have been determined for various
microorganisms, including Escherichia coli (2).
On the basis of these genomic DNA sequences, all of the possible open reading frames (ORFs) can be determined (25), and possible
drug exporter genes have been determined (19). As a
result, it was found that the E. coli chromosome contains
five ORF clusters for possible ABC drug efflux genes (19),
i.e., mdlAB, ybjYZ, yddA, yojHI, and yhiH. Recently, we cloned all of these
putative ABC transporter genes in multicopy plasmids
(14a), and their drug resistance was investigated in
drug-supersensitive strain E. coli KAM3 (12),
which lacks constitutive multidrug efflux transporter genes
acrAB (13). We found that only the
ybjYZ gene products confer macrolide-specific drug
resistance, and the genes were renamed macAB. In this study,
we investigated the macAB gene products and revealed that
they comprise a macrolide efflux transporter system. This is the first
case of an ABC drug efflux transporter being experimentally established
in a gram-negative bacterium.
 |
MATERIALS AND METHODS |
Materials and bacterial strains.
[14C]erythromycin (1.85 GBq/mmol) was purchased from NEN
Life Science Products, Inc. Erythromycin, clarithromycin, rokitamycin, azithromycin, oleandomycin, josamycin, and leucomycin were kindly provided by Takeshi Nishino (Kyoto Pharmaceutical University, Kyoto,
Japan). All other materials were of reagent grade and were obtained
from commercial sources. E. coli AcrAB-deficient strain KAM3
(12) and TolC-deficient strain ZK796 (33)
were kindly provided by Tomofusa Tsuchiya and Yuji Morita (Okayama
University, Okayama, Japan) and by Hiroshi Nikaido (University
of California, Berkeley), respectively. All of the bacterial strains
and plasmids used in this study are listed in Table
1.
Cloning and expression of ORFs encoding putative ABC
transporters.
Chromosomal DNA was isolated from E. coli
W3104 cells as previously described (14). The DNA
fragments including putative ABC transporter ORFs and their upstream
regions containing the natural promoters were amplified by the PCR
method using primers containing the restriction enzyme site that exists
in the multicloning sites of pUC119. The digested DNA fragments
containing ORFs were ligated into the multicloning sites of pUC119 in
the same direction as the lac promoter (Table 1), and
then E. coli KAM3 cells were transformed with these
recombinant DNAs.
pUCmacAB carries the 502-bp upstream region containing the native
promoter, in addition to the entire
macA and
macB
ORFs.
The
macA and
macB ORFs were individually
subcloned into pUC119
as follows. pUCmacA was constructed by subcloning
the
SmaI fragment
of pUCmacAB, in which about one-half of
the
macB ORF was removed
while the 500-bp upstream region
and the entire
macA ORF were
left. For pUCmacB, the
macA ORF was removed from pUCmacAB by means
of crossover
PCR; as a result, the 502-bp upstream region was
directly connected to
the
macB ORF. In order to investigate the
intracellular
localization of MacA and MacB, the
macA and
macB genes were also individually subcloned into plasmid pQE70 (Table
1).
Plasmid pQE70 carries an optimized promoter-operator element
consisting
of the phage T5 promoter, which is recognized by
E. coli RNA
polymerase, and two
lac operator sequences. In addition,
a
six-His tag coding sequence was attached at the 3' terminus
of the
cloned
gene.
Drug resistance determination.
The drug resistance of cells
was determined by means of a sequential twofold dilution method on
yeast extract-Bacto Tryptone agar plates as previously described
(14) without induction, and the results were expressed as
MICs. E. coli KAM3 cells carry the
lacIq gene; thus, the cloned genes are not
expressed from the lac promoter without induction.
Expression of the putative ABC transporter genes was expected from the
native promoters.
Assay of [14C]erythromycin accumulation in E. coli cells.
E. coli KAM3/pUCmacAB and its host
cells were grown in 30 ml of Luria-Bertani broth at 37°C until
they reached an optical density at 600 nm of 0.6. The cells were then
harvested and washed twice with 50 mM potassium phosphate buffer (pH
7.0). The cells were then finally suspended in 7.2 ml of the same
phosphate buffer. The cell suspension (500 µl) was preincubated with
25 mM glucose at 37°C for 1 min. Erythromycin uptake was started by
addition of 5 µl of [14C]erythromycin (1.53-µg/ml
solution). At the indicated times, aliquots (250 µl) were withdrawn
and filtered through Millipore filters (pore size, 0.45 µm). The
filters were washed twice with 700 µl of potassium phosphate buffer,
and then the radioactivity was measured with a liquid scintillation counter.
 |
RESULTS |
Drug resistance phenotypes produced by ORFs encoding putative
ABC drug efflux transporters.
Five putative ABC transporter genes,
mdlAB, macAB, yddA, yojHI,
and yhiH, were cloned into pUC119 under the control of the native promoters as described in Materials and Methods.
Drug-supersensitive strain E. coli KAM3 (12),
which lacks constitutive multidrug efflux transporter AcrAB, was
transformed with these plasmids. The resistance phenotypes of the cells
carrying these plasmids against 22 different drugs and toxic compounds
were determined without induction. The MICs (in parentheses in
micrograms per milliliter) of the following 21 compounds
were unaltered in KAM3 containing mdlAB,
macAB, yddA, yojHI, and
yhiH: chloramphenicol (0.39), tetracycline (0.39),
minocycline (0.20), nalidixic acid (0.78), norfloxacin (0.025),
enoxacin (0.05), vancomycin (200), fosfomycin (1.56), doxorubicin
(3.13), novobiocin (1.56), rifampin (6.25), trimethoprim (3.13),
acriflavine (12.5), crystal violet (1.56), ethidium bromide (12.5),
methylviologen (100), tetraphenylphosphonium bromide;
(6.25), carbonyl cyanide m-chlorophenylhydrazone
(6.25), benzalkonium (3.13), sodium dodecyl sulfate (50), and
deoxycholate (1,250). For cells carrying the macAB
genes, the MIC of erythromycin was 25 µg/ml, which was eight times
higher than the MIC for the host cells (3.13 µg/ml). Plasmids
carrying the other four ORF clusters produced no alteration in the MIC
of erythromycin.
Amino acid sequences of MacA and MacB.
The DNA sequences of
the macAB genes were determined by means of the dideoxy
sequencing method with an ABI PRISM310 Genetic Analyzer. The ORFs of
macA and macB partially overlap; i.e., the sequence ATGA at the end of macA contains the stop codon TGA
for macA and the initiation codon ATG for macB
(Fig. 1A). There is only one promoter
sequence in the upstream region of macA, indicating that
macA and macB form one operon. The DNA sequences
of the macAB region cloned in this study are the same as
those in the reported genome sequence of E. coli
(2). MacA has a signal-like sequence composed of 40 amino
acid residues at its N terminus, which is rich in positively charged
residues in the N-terminal half and hydrophobic residues in the
C-terminal half. There is no hydrophobic cluster in the MacA sequence
except in this region (Fig. 1B). On the other hand, MacB
contains four putative transmembrane (TM) regions in its C-terminal
half (Fig. 1C). The N-terminal half of MacB includes a
nucleotide-binding cassette domain containing Walker A and B and
signature motifs.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
(A) ORFs of macA and macB, which
partially overlap. (B) Hydropathy analysis and prediction of the TM
region of MacA. (C) Hydropathy analysis and prediction of the TM region
of MacB. NBD, nucleotide-binding domain.
|
|
Contributions of MacA, MacB, and the multifunctional outer
membrane channel TolC to resistance against macrolide
antibiotics.
In order to examine the contributions of MacA and
MacB to drug resistance, the macA and macB genes
were separately subcloned in the pUC119 vector under the
control of the natural promoter. The resistance of cells carrying
pUCmacAB, pUCmacA, and pUCmacB against
various macrolide antibiotics is shown in Table
2. Compared with the MIC for the host
KAM3 cells, neither cells carrying pUCmacA nor those carrying
pUCmacB showed an increase in resistance.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Resistance of E. coli KAM3
( acrAB) and ZK796 ( tolC) cells harboring a
plasmid carrying both the macA and -B genes
or one of these genes against macrolide derivatives
|
|
On the other hand, cells carrying pUCmacAB exhibited
increased resistance against the macrolide antibiotics with
14- and 15-membered
rings that were examined. The MICs of
erythromycin, clarithromycin,
azithromycin, and oleandomycin were eight
times as high as those
for the host cells. On the other hand, the MICs
of 16-membered
lactones were increased only twofold (rokitamycin and
josamycin)
or not changed
(leucomycin).
In order to investigate the role of the multifunctional outer membrane
channel TolC in the MacAB system, TolC-deficient
E. coli
ZK796 was transformed with pUCmacAB. The resulting
transformed
cells showed no increase in resistance (Table
2),
indicating
that the MacAB system depends on
TolC.
Intracellular localization of MacA and MacB.
In order to
reveal the intracellular localization of MacA and MacB, the
macA and macB genes were separately
subcloned into vector pQE70 to attach polyhistidine tags at their C
termini. The expression of MacA and MacB was induced with
isopropyl-
-D-thiogalactopyranoside (IPTG). Cells carrying pUCmacAB,
pQEmacA, and pQEmacB were disrupted by brief sonication, and then
supernatants (S) and membrane fractions (P) were obtained by
ultracentrifugation. After sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, total proteins were visualized by Coomassie brilliant
blue (CBB) staining and MacA and MacB were visualized by Western
blotting with anti-polyhistidine serum (Fig.
2A). Both MacA (40 kDa) and MacB (70 kDa)
bands were observed only for the membrane fractions (Fig. 2A, lanes 4 and 5). Both bands were also detected for the membrane fraction
of cells carrying pUCmacAB on CBB staining (Fig. 2A,
lane 3).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
Expression and localization of MacA and MacB. (A)
Expression of MacA and MacB under the control of the native promoter
(pUC plasmids) and the T5 promoter (pQE plasmids) with a
polyhistidine tag at the N-terminal end. In the case of pQE plasmids,
expression was induced with IPTG. Cells were disrupted by brief
sonication, and supernatant (S) and precipitated (membrane) (P)
fractions were obtained by ultracentrifugation after removal of cell
debris by brief low-speed centrifugation. Lanes 1, 2, and 3 were
stained with CBB, and lanes 4 and 5 were visualized by Western
blotting. Lanes: 1, cells carrying pQEmacA; 2, pQEmacB; 3, pUCmacAB; 4, pQEmacA; 5, pQEmacB. (B) Fractionation of
MacA with 4.5 M urea washing or potassium phosphate buffer washing as a
control. Lanes 1, 2, and 3 were stained with CBB, and lanes 4, 5, and 6 were visualized by Western blotting. S and P indicate the
supernatants and precipitates obtained on ultracentrifugation,
respectively. Lanes: 1 and 3, briefly sonicated cells carrying pQEmacA;
2 and 5, after 4.5 M urea washing of the precipitate (lane 1, P); 3 and
6, after potassium phosphate buffer washing of the precipitate (lane 1, P).
|
|
The membrane fraction of cells expressing MacA was treated
with 4.5 M urea, and a supernatant and a precipitate were obtained
by
ultracentrifugation. A significant amount of MacA was released
from the
membrane fraction and detected in the supernatant fraction
by Western
blotting (Fig.
2B, lane 5). In contrast, when the membrane
was treated
with potassium phosphate buffer, MacA was not released
from it (Fig.
2B, lane 6). These observations suggest that MacA
is a peripheral
membrane
protein.
Uptake of [14C]erythromycin by cells carrying
pUCmacAB.
In order to determine whether or not macrolide
resistance is based on the active efflux of drugs, we compared the
uptake of [14C]erythromycin by E. coli KAM3
cells with and without the pUCmacAB plasmid (Fig.
3). [14C]erythromycin was
taken up by the host KAM3 cells. In cells carrying pUCmacAB,
uptake was significantly inhibited, indicating active efflux of
this drug out of the cells.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Accumulation of [14C]erythromycin in
cells carrying pUCmacAB and pUC119. Cells were
incubated with 25 mM glucose and 1.53 µg of
[14C]erythromycin per ml as described in Materials and
Methods. Aliquots were then filtered through Millipore filters. After
washing of the filters, radioactivity was measured with a liquid
scintillation counter. Radioactivity is indicated as
disintegrations per minute. Open symbols, cells carrying
pUCmacAB; closed symbols, cells carrying pUC119.
|
|
 |
DISCUSSION |
In this study, we showed that the MacAB complex confers
TolC-dependent macrolide resistance via active drug efflux. We examined the resistance pattern against 22 different drugs and toxic compounds which contain the typical compounds exported by multidrug transporters in bacteria and mammals. As a result, MacAB was revealed to confer macrolide-specific resistance. As shown in Fig.
4, MacB is a half-type ABC protein
having four putative TM segments and one nucleotide-binding cassette. There is a large hydrophilic loop region between TM1 and TM2,
which is probably located on the periplasmic surface and may interact
with MacA. MacA is a peripheral membrane protein that belongs to the
membrane fusion protein (MFP) family (4). According
to the sequence characteristics of the signal-like sequence and the
positive-inside rule of protein topogenesis (20), most of
the MacA molecule seems to be secreted and attached on the periplasmic surface (Fig. 4).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic model of the molecular construction of the
novel ABC-type macrolide-specific drug exporter MacA-MacB system
complexed with TolC in E. coli. The dotted line indicates
the region having a signal-like sequence. NBD indicates a possible
nucleotide-binding domain having Walker A and B and signature motifs.
|
|
A BLAST search revealed that there are homologues of macAB
in gram-negative organisms. Putative ABC transporter proteins
NMA0729 (16) and NMB0548 (29) in
Neisseria meningitidis, PA2389 in Pseudomonas
aeruginosa (26), and CAB75243.1 in
Campylobacter jejuni (17) exhibit sequence
identity with MacB, i.e., 48, 48, 43, and 41%, respectively. They show
sequence similarity not only in the ATP-binding domains but also in the
TM domains. In contrast, the sequence similarity between MacB and
putative ABC transporters such as MsrA (24) in
gram-positive organisms is restricted to the ATP-binding cassette
region. The putative ABC transporter genes in the gram-negative
organisms mentioned above include genes for MacA homologues in the same
operon. Therefore, these genes can be classified into the same
subfamily of ABC transporters in gram-negative organisms.
In eukaryotes, most ABC transporters are involved in
multidrug resistance. However, in bacteria, the majority of
drug exporters are drug-proton antiporters (8), including
MFS-, SMR-, and RND-type transporters, while ABC
transporters are usually involved in the uptake of a wide range of
molecules (6). On the basis of the results of genome
analysis, a number of putative ABC drug exporters are predicted
(19), while the only ABC multidrug exporter experimentally
identified in a bacterium is LmrA in Lactococcus lactis
(30). In gram-positive organisms, some macrolide
resistance genes code for ABC-type efflux transporter proteins
(22, 24). Among them, MsrAB in Staphylococcus
species has two nucleotide-binding domains and probably acts as
an efflux system in cooperating with some other integral membrane
proteins (10), while its characteristics as a drug
exporter have not been fully revealed. As for macrolide exporters, some major facilitator-type exporters are known in gram-positive organisms (3, 28), such as MefA, which,
similarly to MacAB, confers resistance against macrolides with 14- and
15-membered lactones.
A half-type ABC transporter is usually expected to have six TM
segments (1, 30). MacB appears to have four TM
segments. In addition, the N-terminal ABC on an ABC
transporter is also unusual. Among the ABC transporters hitherto
reported, only the ABCG subfamily in mammalian cells shows an
N-terminal ABC (7). MacB requires the MFP MacA and
the outer membrane channel TolC for drug efflux function. Although
some bacterial ABC transporters such as HlyB (34)
accompany an MFP and TolC, it is quite interesting that ABC-type drug
efflux transporters depend on an MFP and TolC, as seen with
RND-type multidrug efflux transporters (9, 13). In
short, MacAB represents a quite unique and novel
bacterial subfamily of ABC transporters.
Very recently, Sulavik et al. (27) constructed 22 E. coli strains with deletions of putative drug efflux
transporters and outer membrane channels. The strain with a deletion of
the macAB (ybjYZ) genes showed no change in drug
susceptibility. However, since the macAB deletion strain
carried the acrAB genes, the effect of macAB
deletion might have been masked. The tolerance of E. coli
cells to macrolide antibiotics is conferred mainly by AcrAB (35). Expression cloning of an individual gene into an
AcrAB-deficient strain may be necessary to discover a potential drug
efflux transporter gene.
 |
ACKNOWLEDGMENTS |
This work was supported by grants-in-aid from the Ministry of
Education, Culture, Sports, Science and Technology of Japan. K. Nishino
is supported by a Research Fellowship from the Japan Society for the
Promotion of Science for Young Scientists.
K. Nishino and N. Kobayashi contributed equally to this work, and both
should be considered first authors.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka,
Ibaraki-shi, Osaka 567-0047, Japan. Phone: 81-6-6879-8545. Fax:
81-6-6879-8549. E-mail:
akihito{at}sanken.osaka-u.ac.jp.
 |
REFERENCES |
| 1.
|
Abele, R., and R. Tampe.
1999.
Function of the transport complex TAP in cellular immune recognition.
Biochim. Biophys. Acta
1461:405-419[Medline].
|
| 2.
|
Blattner, F. R.,
G. Plunkett,
C. A. Bloch,
N. T. Perna,
V. Burland,
M. Riley,
J. Collado-Vides,
J. D. Glasner,
C. K. Rode,
G. F. Mayhew,
J. Gregor,
N. W. Davis,
H. A. Kirkpatrick,
M. A. Goeden,
D. J. Rose,
B. Mau, and Y. Shao.
1997.
The complete genome sequence of Escherichia coli K-12.
Science
277:1453-1474[Abstract/Free Full Text].
|
| 3.
|
Clancy, J.,
J. Petitpas,
F. Dib-Hajj,
W. Yuan,
M. Cronan,
A. V. Kamath,
J. Bergeron, and J. A. Retsema.
1996.
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.
Mol. Microbiol.
22:867-879[CrossRef][Medline].
|
| 4.
|
Dinh, T.,
I. T. Paulsen, and M. H. Saier.
1994.
A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria.
J. Bacteriol.
176:3825-3831[Abstract/Free Full Text].
|
| 5.
|
Gottesman, M. M., and I. Pastan.
1993.
Biochemistry of multidrug resistance mediated by the multidrug transporter.
Annu. Rev. Biochem.
62:385-427[CrossRef][Medline].
|
| 6.
|
Holland, I. B., and M. A. Blight.
1999.
ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans.
J. Mol. Biol.
293:381-399[CrossRef][Medline].
|
| 7.
|
Klein, I.,
B. Sarkadi, and A. Varadi.
1999.
An inventory of the human ABC proteins.
Biochim. Biophys. Acta
1461:237-262[Medline].
|
| 8.
|
Levy, S. B.
1992.
Active efflux mechanisms for antimicrobial resistance.
Antimicrob. Agents Chemother.
36:695-703[Free Full Text].
|
| 9.
|
Li, X.-Z.,
H. Nikaido, and K. Poole.
1995.
Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
39:1948-1953[Abstract].
|
| 10.
|
Matsuoka, M.,
K. Endou,
H. Kobayashi,
M. Inoue, and Y. Nakajima.
1998.
A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus.
FEMS Microbiol. Lett.
167:221-227[CrossRef][Medline].
|
| 11.
|
McMurry, L.,
R. E. Petrucci, Jr., and S. B. Levy.
1980.
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
Proc. Natl. Acad. Sci. USA
77:3974-3977[Abstract/Free Full Text].
|
| 12.
|
Morita, Y.,
K. Kodama,
S. Shiota,
T. Mine,
A. Kataoka,
T. Mizushima, and T. Tsuchiya.
1998.
NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.
Antimicrob. Agents Chemother.
42:1778-1782[Abstract/Free Full Text].
|
| 13.
|
Nikaido, H., and J. A. Hall.
1998.
Overview of bacterial ABC transporters.
Methods Enzymol.
292:3-20[Medline].
|
| 14.
|
Nishino, K., and A. Yamaguchi.
2001.
Overexpression of the response regulator evgA of the two-component signal transduction system modulates multidrug resistance conferred by multidrug resistance transporters.
J. Bacteriol.
183:1455-1458[Abstract/Free Full Text].
|
| 14a.
| Nishino, K., and A. Yamaguchi. Analysis of a
complete library of putative drug transporter genes in
Escherichia coli. J. Bacteriol., in press.
|
| 15.
|
Okusu, H.,
D. Ma, and H. Nikaido.
1996.
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.
J. Bacteriol.
178:306-308[Abstract/Free Full Text].
|
| 16.
|
Parkhill, J.,
M. Achtman,
K. D. James,
S. D. Bentley,
C. Churcher,
S. R. Klee,
G. Morelli,
D. Basham,
D. Brown,
T. Chillingworth,
R. M. Davies,
P. Davis,
K. Devlin,
T. Feltwell,
N. Hamlin,
S. Holroyd,
K. Jagels,
S. Leather,
S. Moule,
K. Mungall,
M. A. Quail,
M. A. Rajandream,
K. M. Rutherford,
M. Simmonds,
J. Skelton,
S. Whitehead,
B. G. Spratt, and B. G. Barrell.
2000.
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491.
Nature
404:502-506[CrossRef][Medline].
|
| 17.
|
Parkhill, J.,
B. W. Wren,
K. Mungall,
J. M. Ketley,
C. Churcher,
D. Basham,
T. Chillingworth,
R. M. Davies,
T. Feltwell,
S. Holroyd,
K. Jagels,
A. V. Karlyshev,
S. Moule,
M. J. Pallen,
C. W. Penn,
M. A. Quail,
M.-A. Rajandream,
K. M. Rutherford,
A. H. van Vliet,
S. Whitehead, and B. G. Barrell.
2000.
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.
Nature
403:665-668[CrossRef][Medline].
|
| 18.
|
Paulsen, I. T.,
R. A. Skurray,
R. Tam,
M. H. Saier, Jr.,
R. J. Turner,
J. H. Weiner,
E. B. Goldberg, and L. L. Grinius.
1996.
The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs.
Mol. Microbiol.
19:1167-1175[Medline].
|
| 19.
|
Paulsen, I. T.,
M. K. Sliwinski, and M. H. Saier, Jr.
1998.
Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities.
J. Mol. Biol.
277:573-592[CrossRef][Medline].
|
| 20.
|
Persson, B., and P. Argos.
1996.
Topology prediction of membrane proteins.
Protein Sci.
5:363-371[Medline].
|
| 21.
|
Reizer, J.,
A. Reizer, and M. H. Saier, Jr.
1992.
A new subfamily of bacterial ABC-type transport systems catalyzing export of drugs and carbohydrates.
Protein Sci.
1:1326-1332[Medline].
|
| 22.
|
Roberts, M. C.,
J. Sutcliffe,
P. Courvalin,
L. B. Jensen,
J. Rood, and H. Seppala.
1999.
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.
Antimicrob. Agents Chemother.
43:2823-2830[Free Full Text].
|
| 23.
|
Rosen, B. P.
1999.
Families of arsenic transporters.
Trends Microbiol.
7:207-212[CrossRef][Medline].
|
| 24.
|
Ross, J. I.,
E. A. Eady,
J. H. Cove,
W. J. Cunliffe,
S. Baumberg, and J. C. Wootton.
1990.
Inducible erythromycin resistance in Staphylococci is encoded by a member of the ATP-binding transport super-gene family.
Mol. Microbiol.
4:1207-1214[CrossRef][Medline].
|
| 25.
|
Rudd, K. E.
1998.
Linkage map of Escherichia coli K-12, edition 10: the physical map.
Microbiol. Mol. Biol. Rev.
62:985-1019[Abstract/Free Full Text].
|
| 26.
|
Stover, C. K.,
X. Q. Pham,
A. L. Erwin,
S. D. Mizoguchi,
P. Warrener,
M. J. Hickey,
F. S. Brinkman,
W. O. Hufnagle,
D. J. Kowalik,
M. Lagrou,
R. L. Garber,
L. Goltry,
E. Tolentino,
S. Westbrock-Wadman,
Y. Yuan,
L. L. Brody,
S. N. Coulter,
K. R. Folger,
A. Kas,
K. Larbig,
R. Lim,
K. Smith,
D. Spencer,
G. K. Wong,
Z. Wu,
I. T. Paulsen,
J. Reizer,
M. H. Saier,
R. E. W. Hancock,
S. Lory, and M. V. Olson.
2000.
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.
Nature
406:959-964[CrossRef][Medline].
|
| 27.
|
Sulavik, M. C.,
C. Houseweart,
C. Cramer,
N. Jiwani,
N. Murgolo,
J. Greene,
B. Didomenico,
K. J. Shaw,
G. H. Miller,
R. Hare, and G. Shimer.
2001.
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes.
Antimicrob. Agents Chemother.
45:1126-1136[Abstract/Free Full Text].
|
| 28.
|
Sutcliffe, J.,
A. Tait-Kamradt, and L. Wondrack.
1996.
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
Antimicrob. Agents Chemother.
40:1817-1824[Abstract].
|
| 29.
|
Tettelin, H.,
N. J. Saunders,
J. Heidelberg,
A. C. Jeffries,
K. E. Nelson,
J. A. Eisen,
K. A. Ketchum,
D. W. Hood,
J. F. Peden,
R. J. Dodson,
W. C. Nelson,
M. L. Gwinn,
R. DeBoy,
J. D. Peterson,
E. K. Hickey,
D. H. Haft,
S. L. Salzberg,
O. White,
R. D. Fleischmann,
B. A. Dougherty,
T. Mason,
A. Ciecko,
D. S. Parksey,
E. Blair,
H. Cittone,
E. B. Clark,
M. D. Cotton,
T. R. Utterback,
H. Khouri,
H. Qin,
J. Vamathevan,
J. Gill,
V. Scarlato,
V. Masignani,
M. Pizza,
G. Grandi,
L. Sun,
H. O. Smith,
C. M. Fraser,
E. R. Moxon,
R. Rappuoli, and J. C. Venter.
2000.
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.
Science
287:1809-1815[Abstract/Free Full Text].
|
| 30.
|
van Veen, H. W.,
K. Venema,
H. Bolhuis,
I. Oussenko,
J. Kok,
B. Poolman,
A. J. Driessen, and W. N. Konings.
1996.
Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.
Proc. Natl. Acad. Sci. USA
93:10668-10672[Abstract/Free Full Text].
|
| 31.
|
Yamaguchi, A.,
T. Udagawa, and T. Sawai.
1990.
Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein.
J. Biol. Chem.
265:4809-4813[Abstract/Free Full Text].
|
| 32.
|
Young, J., and I. B. Holland.
1999.
ABC transporters: bacterial exporters-revisited five years on.
Biochim. Biophys. Acta
1461:177-200[Medline].
|
| 33.
|
Zgurskaya, H. I., and H. Nikaido.
2000.
Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli.
J. Bacteriol.
182:4264-4267[Abstract/Free Full Text].
|
| 34.
|
Zhang, F.,
J. A. Sheps, and V. Ling.
1993.
Complementation of transport-deficient mutants of Escherichia coli alpha-hemolysin by second-site mutations in the transporter hemolysin B.
J. Biol. Chem.
268:19889-19895[Abstract/Free Full Text].
|
| 35.
|
Zhong, P., and V. D. Shortridge.
2000.
The role of efflux in macrolide resistance.
Drug Resist. Updates
3:325-329[CrossRef][Medline].
|
Journal of Bacteriology, October 2001, p. 5639-5644, Vol. 183, No. 19
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.19.5639-5644.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Arends, S. J. R., Kustusch, R. J., Weiss, D. S.
(2009). ATP-Binding Site Lesions in FtsE Impair Cell Division. J. Bacteriol.
191: 3772-3784
[Abstract]
[Full Text]
-
Lin, H. T., Bavro, V. N., Barrera, N. P., Frankish, H. M., Velamakanni, S., van Veen, H. W., Robinson, C. V., Borges-Walmsley, M. I., Walmsley, A. R.
(2009). MacB ABC Transporter Is a Dimer Whose ATPase Activity and Macrolide-binding Capacity Are Regulated by the Membrane Fusion Protein MacA. J. Biol. Chem.
284: 1145-1154
[Abstract]
[Full Text]
-
Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeno-Tarraga, A. M., Thomson, N. R., Bason, N., Quail, M. A., Sharp, S., Cherevach, I., Churcher, C., Goodhead, I., Hauser, H., Holroyd, N., Mungall, K., Scott, P., Walker, D., White, B., Rose, H., Iversen, P., Mil-Homens, D., Rocha, E. P. C., Fialho, A. M., Baldwin, A., Dowson, C., Barrell, B. G., Govan, J. R., Vandamme, P., Hart, C. A., Mahenthiralingam, E., Parkhill, J.
(2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients. J. Bacteriol.
191: 261-277
[Abstract]
[Full Text]
-
Yamanaka, H., Kobayashi, H., Takahashi, E., Okamoto, K.
(2008). MacAB Is Involved in the Secretion of Escherichia coli Heat-Stable Enterotoxin II. J. Bacteriol.
190: 7693-7698
[Abstract]
[Full Text]
-
Moore, S. D., Sauer, R. T.
(2008). Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc. Natl. Acad. Sci. USA
105: 18261-18266
[Abstract]
[Full Text]
-
Jacquet, E., Girard, J.-M., Ramaen, O., Pamlard, O., Levaique, H., Betton, J.-M., Dassa, E., Chesneau, O.
(2008). ATP Hydrolysis and Pristinamycin IIA Inhibition of the Staphylococcus aureus Vga(A), a Dual ABC Protein Involved in Streptogramin A Resistance. J. Biol. Chem.
283: 25332-25339
[Abstract]
[Full Text]
-
Dubern, J.-F., Coppoolse, E. R., Stiekema, W. J., Bloemberg, G. V.
(2008). Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. Microbiology
154: 2070-2083
[Abstract]
[Full Text]
-
Davidson, A. L., Dassa, E., Orelle, C., Chen, J.
(2008). Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems. Microbiol. Mol. Biol. Rev.
72: 317-364
[Abstract]
[Full Text]
-
de Bruijn, I., de Kock, M. J. D., de Waard, P., van Beek, T. A., Raaijmakers, J. M.
(2008). Massetolide A Biosynthesis in Pseudomonas fluorescens. J. Bacteriol.
190: 2777-2789
[Abstract]
[Full Text]
-
Matsuo, T., Chen, J., Minato, Y., Ogawa, W., Mizushima, T., Kuroda, T., Tsuchiya, T.
(2008). SmdAB, a Heterodimeric ABC-Type Multidrug Efflux Pump, in Serratia marcescens. J. Bacteriol.
190: 648-654
[Abstract]
[Full Text]
-
Kamal, N., Rouquette-Loughlin, C., Shafer, W. M.
(2007). The TolC-Like Protein of Neisseria meningitidis Is Required for Extracellular Production of the Repeats-in-Toxin Toxin FrpC but Not for Resistance to Antimicrobials Recognized by the Mtr Efflux Pump System. Infect. Immun.
75: 6008-6012
[Abstract]
[Full Text]
-
Murata, T., Tseng, W., Guina, T., Miller, S. I., Nikaido, H.
(2007). PhoPQ-Mediated Regulation Produces a More Robust Permeability Barrier in the Outer Membrane of Salmonella enterica Serovar Typhimurium. J. Bacteriol.
189: 7213-7222
[Abstract]
[Full Text]
-
Lubelski, J., Konings, W. N., Driessen, A. J. M.
(2007). Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria. Microbiol. Mol. Biol. Rev.
71: 463-476
[Abstract]
[Full Text]
-
Perez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., del Mar Tomas, M., Fernandez, A., Mallo, S., Perez, S., Molina, F., Villanueva, R., Lasa, I., Bou, G.
(2007). Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate. Antimicrob. Agents Chemother.
51: 3247-3253
[Abstract]
[Full Text]
-
Bogdanovich, T., Bozdogan, B., Appelbaum, P. C.
(2006). Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae. Antimicrob. Agents Chemother.
50: 893-898
[Abstract]
[Full Text]
-
Wang, N., Lu, S.-E., Yang, Q., Sze, S.-H., Gross, D. C.
(2006). Identification of the syr-syp Box in the Promoter Regions of Genes Dedicated to Syringomycin and Syringopeptin Production by Pseudomonas syringae pv. syringae B301D. J. Bacteriol.
188: 160-168
[Abstract]
[Full Text]
-
Rouquette-Loughlin, C. E., Balthazar, J. T., Shafer, W. M.
(2005). Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J Antimicrob Chemother
56: 856-860
[Abstract]
[Full Text]
-
Bleuel, C., Grosse, C., Taudte, N., Scherer, J., Wesenberg, D., Krauss, G. J., Nies, D. H., Grass, G.
(2005). TolC Is Involved in Enterobactin Efflux across the Outer Membrane of Escherichia coli. J. Bacteriol.
187: 6701-6707
[Abstract]
[Full Text]
-
Poole, K.
(2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother
56: 20-51
[Abstract]
[Full Text]
-
Chesneau, O., Ligeret, H., Hosan-Aghaie, N., Morvan, A., Dassa, E.
(2005). Molecular Analysis of Resistance to Streptogramin A Compounds Conferred by the Vga Proteins of Staphylococci. Antimicrob. Agents Chemother.
49: 973-980
[Abstract]
[Full Text]
-
Nishino, K., Honda, T., Yamaguchi, A.
(2005). Genome-Wide Analyses of Escherichia coli Gene Expression Responsive to the BaeSR Two-Component Regulatory System. J. Bacteriol.
187: 1763-1772
[Abstract]
[Full Text]
-
Igarashi, Y., Aoki, K. F., Mamitsuka, H., Kuma, K.-i., Kanehisa, M.
(2004). The Evolutionary Repertoires of the Eukaryotic-Type ABC Transporters in Terms of the Phylogeny of ATP-binding Domains in Eukaryotes and Prokaryotes. Mol Biol Evol
21: 2149-2160
[Abstract]
[Full Text]
-
Chollet, R., Chevalier, J., Bryskier, A., Pages, J.-M.
(2004). The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother.
48: 3621-3624
[Abstract]
[Full Text]
-
Chou, H.-C., Lee, C.-Z., Ma, L.-C., Fang, C.-T., Chang, S.-C., Wang, J.-T.
(2004). Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection. Infect. Immun.
72: 3783-3792
[Abstract]
[Full Text]
-
Nishino, K., Yamaguchi, A.
(2004). Role of Histone-Like Protein H-NS in Multidrug Resistance of Escherichia coli. J. Bacteriol.
186: 1423-1429
[Abstract]
[Full Text]
-
Schmidt, K. L., Peterson, N. D., Kustusch, R. J., Wissel, M. C., Graham, B., Phillips, G. J., Weiss, D. S.
(2004). A Predicted ABC Transporter, FtsEX, Is Needed for Cell Division in Escherichia coli. J. Bacteriol.
186: 785-793
[Abstract]
[Full Text]
-
Nishino, K., Yamada, J., Hirakawa, H., Hirata, T., Yamaguchi, A.
(2003). Roles of TolC-Dependent Multidrug Transporters of Escherichia coli in Resistance to {beta}-Lactams. Antimicrob. Agents Chemother.
47: 3030-3033
[Abstract]
[Full Text]
-
Huda, N., Lee, E.-W., Chen, J., Morita, Y., Kuroda, T., Mizushima, T., Tsuchiya, T.
(2003). Molecular Cloning and Characterization of an ABC Multidrug Efflux Pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob. Agents Chemother.
47: 2413-2417
[Abstract]
[Full Text]
-
Sheehan, B. J., Bosse, J. T., Beddek, A. J., Rycroft, A. N., Kroll, J. S., Langford, P. R.
(2003). Identification of Actinobacillus pleuropneumoniae Genes Important for Survival during Infection in Its Natural Host. Infect. Immun.
71: 3960-3970
[Abstract]
[Full Text]
-
Van Bambeke, F., Glupczynski, Y., Plesiat, P., Pechere, J. C., Tulkens, P. M.
(2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother
51: 1055-1065
[Full Text]
-
Nishino, K., Inazumi, Y., Yamaguchi, A.
(2003). Global Analysis of Genes Regulated by EvgA of the Two-Component Regulatory System in Escherichia coli. J. Bacteriol.
185: 2667-2672
[Abstract]
[Full Text]
-
Hirakawa, H., Nishino, K., Hirata, T., Yamaguchi, A.
(2003). Comprehensive Studies of Drug Resistance Mediated by Overexpression of Response Regulators of Two-Component Signal Transduction Systems in Escherichia coli. J. Bacteriol.
185: 1851-1856
[Abstract]
[Full Text]
-
Mc Dermott, P. F., Walker, R. D., White, D. G.
(2003). Antimicrobials: Modes of Action and Mechanisms of Resistance. International Journal of Toxicology
22: 135-143
[Abstract]
-
Masuda, N., Church, G. M.
(2002). Escherichia coli Gene Expression Responsive to Levels of the Response Regulator EvgA. J. Bacteriol.
184: 6225-6234
[Abstract]
[Full Text]
-
Nagakubo, S., Nishino, K., Hirata, T., Yamaguchi, A.
(2002). The Putative Response Regulator BaeR Stimulates Multidrug Resistance of Escherichia coli via a Novel Multidrug Exporter System, MdtABC. J. Bacteriol.
184: 4161-4167
[Abstract]
[Full Text]
-
Nishino, K., Yamaguchi, A.
(2002). EvgA of the Two-Component Signal Transduction System Modulates Production of the YhiUV Multidrug Transporter in Escherichia coli. J. Bacteriol.
184: 2319-2323
[Abstract]
[Full Text]
-
Nishino, K., Yamaguchi, A.
(2001). Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli. J. Bacteriol.
183: 5803-5812
[Abstract]
[Full Text]